Antibiotic Therapy in Infections of the Diabetic Foot Syndrome
DFO
Antibiotische Therapie In Infektionen Des Diabetischen Fusssyndroms
1 other identifier
observational
80
1 country
1
Brief Summary
This retrospective study examines the surgical and antibiotic treatment of diabetic foot syndrome infections treated at the University Hospital Basel since 2019. It analyses the implementation of the hospital in-house guidelines published in 2019 with regard to antibiotic therapy in diabetic foot infections, taking into account clinical, microbiological and histopathological criteria. The defined endpoints are (i) fully compliant with internal policies, (ii) partially compliant with internal policies, and (iii) not compliant with internal policies. The recording of these proportions is descriptive.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for all trials
Started Oct 2022
Shorter than P25 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
October 12, 2022
CompletedFirst Submitted
Initial submission to the registry
November 7, 2022
CompletedFirst Posted
Study publicly available on registry
November 15, 2022
CompletedPrimary Completion
Last participant's last visit for primary outcome
March 31, 2023
CompletedStudy Completion
Last participant's last visit for all outcomes
April 30, 2023
CompletedJuly 3, 2024
July 1, 2024
6 months
November 7, 2022
July 2, 2024
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Compliance with the hospital in-house guidelines for diabetic foot infections with regard to antibiotic treatment
Implementation of the guidelines published in 2019 with regard to antibiotic therapy in diabetic foot infections, taking into account clinical, microbiological and histopathological criteria. The defined endpoints are (i) fully compliant with internal policies, (ii) partially compliant with internal policies, and (iii) not compliant with internal policies.
one time assessment at baseline
Secondary Outcomes (2)
Duration of antibiotic therapy (days)
one time assessment at baseline
Relapse of diabetic foot infections (number)
one time assessment at baseline
Interventions
Data collection: on (surgical and antibiotic) treatment and implementation of the recommendations published 2019 with regard to the duration of antibiotic therapy.
Eligibility Criteria
The data in this retrospective study derive from everyday clinical work, collected between January 1st, 2019 and December 31st, 2021 at the Department of Infectiology and Department of Orthopaedics and Traumatology at the University Hospital Basel.
You may qualify if:
- soft tissue infection or bone infection (incl. osteomyelitis) in diabetic foot syndrome
- inpatient stay at the University Hospital Basel between January 1st, 2019 and December 31st, 2021
- surgical intervention (amputation and/or debridement)
- signed general consent
You may not qualify if:
- datasets without a diagnosis of the diabetic foot
- no surgical intervention performed (amputation and/or debridement)
- surgical interventions performed by disciplines other than orthopaedics/traumatology (e.g. vascular surgery)
- infections in osteosynthesis material (implant or fracture-associated infections)
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
University Hospital Basel, Orthopedics and Traumatology
Basel, 4031, Switzerland
Related Publications (1)
Reinert N, Wetzel K, Franzeck F, Morgenstern M, Aschwanden M, Wolff T, Clauss M, Sendi P. What is the agreement between principles and practice of antibiotic stewardship in the management of diabetic foot infection: an in-hospital quality control study. J Bone Jt Infect. 2024 Jun 28;9(3):183-190. doi: 10.5194/jbji-9-183-2024. eCollection 2024.
PMID: 39040989RESULT
Related Links
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Andreas Marc Müller, Prof. Dr. med.
Department of Orthopaedics and Traumatology, University Hospital Basel
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- RETROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
November 7, 2022
First Posted
November 15, 2022
Study Start
October 12, 2022
Primary Completion
March 31, 2023
Study Completion
April 30, 2023
Last Updated
July 3, 2024
Record last verified: 2024-07